Crohn's disease trials in Singapore

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Where

  Singapore

  Age

  16 years to 80 years

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06430801 · EU 2023-508636-61-00
• Phase 2Taking people
  Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  Where

  Singapore

  Age

  18 years to 75 years

  People

  590 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06548542 · EU 2024-513009-30-00